Friday, April 25, 2025 10:28:59 PM
I may be wrong, but I believe investors, who may have had knowledge of what was happening at certain sites, reported inspections, I don't remember the company actually reporting it, though perhaps DI let something slip, that's really not official.
If you look at the official Europeant timeline, they have two RFI periods built in with up to 3 months in each. I believe that the UK operates that way, even if it's not documented that way. If you look at that, we're really not that far out of the time that's anticipated. Clearly the British have been slowed by Covid, other approvals have been coming that began at about the same time we filed. I certainly wasn't expecting it to take so long, I've gained a respect for the FDA and their PDUFA dates, but it seems that the UK and Europe are all taking this kind of time on many of their approvals. I still strongly believe that no answers come much faster, and the sponsors are told what actions are needed to gain approval the next time, if they meet requirements. A confirmational trial may be required, but I think our odds of approval are 99+%.
Gary
If you look at the official Europeant timeline, they have two RFI periods built in with up to 3 months in each. I believe that the UK operates that way, even if it's not documented that way. If you look at that, we're really not that far out of the time that's anticipated. Clearly the British have been slowed by Covid, other approvals have been coming that began at about the same time we filed. I certainly wasn't expecting it to take so long, I've gained a respect for the FDA and their PDUFA dates, but it seems that the UK and Europe are all taking this kind of time on many of their approvals. I still strongly believe that no answers come much faster, and the sponsors are told what actions are needed to gain approval the next time, if they meet requirements. A confirmational trial may be required, but I think our odds of approval are 99+%.
Gary
Recent NWBO News
- Northwest Biotherapeutics Announces Establishment Of the Company's Own Dedicated Leukapheresis Clinic • PR Newswire (US) • 04/21/2026 01:30:00 PM
- Northwest Biotherapeutics Announces Establishment Of the Company's Own Dedicated Leukapheresis Clinic • PR Newswire (US) • 04/21/2026 01:30:00 PM
- Form EFFECT - Notice of Effectiveness • Edgar (US Regulatory) • 04/21/2026 04:15:08 AM
- Form POS AM - Post-Effective amendments for registration statement • Edgar (US Regulatory) • 04/16/2026 09:25:30 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 04/07/2026 04:30:50 PM
- Form NT 10-K - Notification of inability to timely file Form 10-K 405, 10-K, 10-KSB 405, 10-KSB, 10-KT, or 10-KT405 • Edgar (US Regulatory) • 03/31/2026 09:04:37 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 01/15/2026 10:06:20 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 01/02/2026 10:14:59 PM
- Form DEF 14A - Other definitive proxy statements • Edgar (US Regulatory) • 11/28/2025 09:43:27 PM
- Form 424B5 - Prospectus [Rule 424(b)(5)] • Edgar (US Regulatory) • 11/25/2025 10:23:07 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 11/20/2025 09:26:03 PM
- Form PRE 14A - Other preliminary proxy statements • Edgar (US Regulatory) • 11/19/2025 09:15:48 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 11/14/2025 09:44:21 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 10/31/2025 04:29:10 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 10/30/2025 08:40:05 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 10/24/2025 04:28:38 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 10/14/2025 06:22:26 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 08/14/2025 09:00:38 PM
- Form 424B5 - Prospectus [Rule 424(b)(5)] • Edgar (US Regulatory) • 07/01/2025 09:04:38 PM
